Skip Navigation

European Heart Journal 1991 12(Supplement D):88-94; doi:10.1093/eurheartj/12.suppl_D.88
Copyright © 1991 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Scheerder, I. K.
Right arrow Articles by Wieme, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Scheerder, I. K.
Right arrow Articles by Wieme, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 The European Society of Cardiology

Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease

I. K. De Scheerder, M. De Buyzere, J. Delanghe, A. Maas, D. L. Clement and R. Wieme

From the Departments of Cardiology and Clinical Chemistry, University Hospital Ghent, Belgium

Address for correspondence: Ivan De Scheerder, University Hospital Gasthuisberg Herestraat, 49, 3000 Leuven, Belgium

Sensitive and highly specific ELISA assays were developed to determine humoral immune response against actin and myosin in 122 patients suffering from various cardiovascular diseases: acute viral myocarditis (n = 10, MYO), acute myocardial infarction (n = 28, AMI), valve surgery (n = 35, VALVE), coronary bypass surgery (n = 35, CABG), and peripheral vascular surgery (n = 14, VASC). Anti-actin and anti-myosin antibodies were determined on admission and serially during a period of 90 days. Anti-actin and anti-myosin immune response (IgG, IgM) was expressed comparing absorbance of the patients' serum with a reference serum. In the different patient groups significantly (P<0·01) higher anti-actin and anhi-myosin antibody concentrations were found on admission compared with age-matched control groups. During follow-up, all patient groups except the vascular surgery group showed a significant immune response against actin and myosin, with an immune response ratio (peak/admission) for AMA IgG and IgM respectively of 2·12 and 2·40 in the VALVE group, 1·30 and 1·99 in the CABG group, 1·42 and 1·48 in the AMI group and 1·66 and 1·25 in the MYO group; and for AAA IgG and IgM respectively of 1·57 and 3·00 in the VALVE group, 1·54 and 1·64 in the CABG group, 1·25 and 1·07 in the AMI group, and 1·42 and 1·42 in the MYO group. A significant correlation between pre-cardiac injury and peak post-cardiac injury anti-myosin and anti-actin autoantibody levels could be demonstrated suggesting that pre-injury sensitization to these antigens plays an important role in evoking post-cardiac injury immune response. Furthermore, a significant correlation between the clinical classification of post-cardiac injury syndrome and the humoral immune response could be demonstrated indicating the importance of immune response in the pathogenesis of this complication after cardiac surgery and acute myocardial infarction.

Key Words: Post cardiac injury syndrome • ELISA • anti-actin antibodies • anti-myosin antibodies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.